Amicus Therapeutics Newsroom

J.P. Morgan Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Announces Target Price $17

Futu NewsNov 13 01:32

J.P. Morgan Maintains Amicus Therapeutics(FOLD.US) With Buy Rating

Futu NewsNov 8 21:32

A Quick Look at Today's Ratings for Amicus Therapeutics(FOLD.US), With a Forecast Between $15 to $21

Futu NewsNov 8 21:15

Amicus Therapeutics Is Maintained at Buy by Guggenheim

Dow JonesNov 8 03:34

Cantor Fitzgerald Maintains Overweight on Amicus Therapeutics, Raises Price Target to $21

BenzingaNov 7 23:44

A Quick Look at Today's Ratings for Amicus Therapeutics(FOLD.US), With a Forecast Between $15 to $20

Futu NewsNov 7 21:10

Amicus Therapeutics Analyst Ratings

BenzingaNov 7 17:49

Amicus Therapeutics: Strong Financial Performance and Growth Prospects Justify Buy Rating

TipRanksNov 7 03:07

TD Cowen Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $20

Futu NewsOct 23 19:31

BofA Securities Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Raises Target Price to $15

Futu NewsOct 18 20:32

B of A Securities Maintains Buy on Amicus Therapeutics, Raises Price Target to $15

BenzingaOct 18 01:00

Amicus Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow JonesOct 12 00:32

Amicus Therapeutics Analyst Ratings

BenzingaOct 12 00:23

Morgan Stanley Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Cuts Target Price to $18

Futu NewsOct 11 20:31

Amicus Therapeutics Price Target Maintained With a $20.00/Share by Cantor Fitzgerald

Dow JonesSep 21 00:25

Jefferies Initiates Amicus Therapeutics(FOLD.US) With Buy Rating, Announces Target Price $18

Futu NewsSep 6 17:31

Amicus Therapeutics Analyst Ratings

BenzingaAug 16 20:08

JP Morgan Maintains Overweight on Amicus Therapeutics, Lowers Price Target to $16

BenzingaAug 16 20:08

J.P. Morgan Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Cuts Target Price to $16

Futu NewsAug 16 19:34

Amicus Therapeutics Analyst Ratings

BenzingaAug 9 17:34